Table 2 Summary of results from the present follow-up at mean 40.7 years after onset of uveitis. The right column shows separate data from the subgroup of 13 patients that were assessed to have active uveitis in this follow-up

Number of years from onset of uveitis

mean 40.7 ± 6.3

(median 39.0, range 35–63)

39.3 ± 5.2

(median 38.0, range 35–55)

Patient age at follow-up (years)

mean 46.9 ± 6.9

(median 45.5, range 38–72)

46.2 ± 6.2

(median 46.0, range 38–57)

Number of patients participating

30

13

(% of original cohort)

(54.5)

(23.6)

Female sex (%)

16 (53.3)

5

Number of patient records studied

26

13

 O

26

12

 P

2

0

 S

2

1

ANA^b at diagnosis (%+)

23+ (76.6)

9+ (69.2)

6 –

4 -

1 u

0 u

Female sex with ANA+ (%)

11 (47.8)

3

Presence of HLA-B27^c (%+)

8 + (26.6)

5+ (38.4)

18 –

7-

4 u

1 u

Female sex with HLA-B27 (%)

2 (25)

1

Patients with cataracts (%)

20 (66.6)

11 (84.6)

Female sex with cataracts

11

5

Patients with glaucom or ocular hypertension (G/OH) (%)

12 (40.0)

8 (61.5)

Female sex with G/OH

5

3

Patients with severe visual impairment both eyes (%)

3 (10)

0

Female sex with severe visual impairment both eyes

1

0

Single eyes with severe visual impairment^d (%)

14 (23.3)

5 (19.2)

Female sex, single eyes with severe visual impairment

7

3

Patients with mild or no visual impairment best eye (%)

20 (66.6)

11 (84.6)

Female sex with mild or no visual impairment best eye

11

4

Single eyes with mild or no visual impairment (%)

36 (60)

18 (78.2)

Female sex with mild or no visual impairment

20

6